Ultragenyx Pharmaceutical Inc.

Connor, Clark & Lunn Investment Management Ltd. RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

263,869

Value ($000)

6,069

Weight

0.0%

2020 Q4 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	6,069	0.0%	263,869	12/31/2025
2025 Q3	11/13/2025	2,374	0.0%	78,922	9/30/2025
2025 Q2	8/7/2025	214	0.0%	5,885	6/30/2025
2025 Q1	5/12/2025	1,626	0.0%	44,901	3/31/2025
2024 Q4	2/10/2025	1,137	0.0%	27,016	12/31/2024
2024 Q3	11/8/2024	4,181	0.0%	75,265	9/30/2024
2024 Q2	8/9/2024	6,695	0.0%	162,891	6/30/2024
2024 Q1	5/9/2024	7,261	0.0%	155,525	3/31/2024
2023 Q4	2/9/2024	4,134	0.0%	86,457	12/31/2023
2023 Q3	11/13/2023	6,497	0.0%	182,235	9/30/2023
2023 Q2	8/10/2023	9,504	0.0%	206,031	6/30/2023
2023 Q1	5/10/2023	8,335	0.0%	207,858	3/31/2023
2022 Q4	2/10/2023	10,665	0.1%	230,194	12/31/2022
2022 Q3	11/10/2022	7,803	0.1%	188,421	9/30/2022
2022 Q2	8/5/2022	1,944	0.0%	32,581	6/30/2022
2021 Q2	8/12/2021	225	0.0%	2,357	6/30/2021
2021 Q1	5/13/2021	1,761	0.0%	15,466	3/31/2021
2020 Q4	2/16/2021	364	0.0%	2,626	12/31/2020